Covivio
GSEFF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Revenue | $564,500 | $573,810 | $585,627 | $658,657 |
| % Growth | -1.6% | -2% | -11.1% | – |
| Cost of Goods Sold | $99,600 | $40,201 | $101,801 | $32,822 |
| Gross Profit | $464,900 | $466,493 | $510,507 | $462,392 |
| % Margin | 82.4% | 81.3% | 87.2% | 70.2% |
| R&D Expenses | $0 | $0 | $0 | $10,648 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $1,000 | $215,461 | $544 | $1,765 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | -$198,500 | -$57,068 | $343,061 | $1,267,553 |
| Operating Expenses | -$197,500 | $158,393 | $343,605 | $1,279,966 |
| Operating Income | $662,400 | $251,032 | $224,168 | $222,378 |
| % Margin | 117.3% | 43.7% | 38.3% | 33.8% |
| Other Income/Exp. Net | -$91,800 | -$98,426 | $0 | -$1,285,885 |
| Pre-Tax Income | $570,600 | $152,606 | $68,294 | -$1,063,507 |
| Tax Expense | $67,200 | $22,293 | $1,207 | -$86,310 |
| Net Income | $341,400 | $76,564 | -$8,364 | -$729,074 |
| % Margin | 60.5% | 13.3% | -1.4% | -110.7% |
| EPS | 3.08 | 0.69 | -0.081 | -7.28 |
| % Growth | 346.4% | 949.8% | 98.9% | – |
| EPS Diluted | 3.06 | 0.69 | -0.081 | -7.28 |
| Weighted Avg Shares Out | 111,569 | 110,790 | 102,963 | 100,134 |
| Weighted Avg Shares Out Dil | 111,423 | 110,790 | 102,963 | 100,134 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $22,734 | $20,366 | $10,648 |
| Interest Expense | $84,600 | $0 | $0 | $166,290 |
| Depreciation & Amortization | $66,900 | $77,819 | $35,081 | $38,805 |
| EBITDA | $470,100 | $328,851 | $472,049 | $261,183 |
| % Margin | 83.3% | 57.3% | 80.6% | 39.7% |